45.14
前日終値:
$43.06
開ける:
$43.73
24時間の取引高:
26.30M
Relative Volume:
1.27
時価総額:
$67.09B
収益:
$20.62B
当期純損益:
$3.56B
株価収益率:
18.93
EPS:
2.3847
ネットキャッシュフロー:
$3.48B
1週間 パフォーマンス:
+2.13%
1か月 パフォーマンス:
-5.33%
6か月 パフォーマンス:
-52.34%
1年 パフォーマンス:
-56.44%
Boston Scientific Corp Stock (BSX) Company Profile
名前
Boston Scientific Corp
セクター
電話
508-683-4000
住所
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BSX
Boston Scientific Corp
|
45.14 | 63.44B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
ABT
Abbott Laboratories
|
95.40 | 158.05B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
326.54 | 120.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
83.19 | 100.14B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
EW
Edwards Lifesciences Corp
|
94.37 | 52.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-30 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | ダウングレード | Erste Group | Buy → Hold |
| 2025-09-08 | アップグレード | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 開始されました | Leerink Partners | Outperform |
| 2025-04-16 | アップグレード | Needham | Hold → Buy |
| 2025-01-10 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-10-18 | ダウングレード | Needham | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2024-02-01 | アップグレード | Mizuho | Neutral → Buy |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-06-30 | 開始されました | CL King | Buy |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2022-12-22 | 開始されました | Mizuho | Neutral |
| 2022-12-20 | 再開されました | Citigroup | Buy |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-06 | 開始されました | Wolfe Research | Outperform |
| 2022-05-27 | アップグレード | Needham | Hold → Buy |
| 2022-04-13 | 再開されました | Truist | Buy |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-05-26 | ダウングレード | Needham | Buy → Hold |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-17 | 開始されました | Truist | Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
| 2020-04-22 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | アップグレード | Goldman | Neutral → Buy |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Buy |
| 2019-12-30 | 繰り返されました | Cowen | Outperform |
| 2019-12-19 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-09-05 | 再開されました | JP Morgan | Overweight |
| 2019-09-03 | 再開されました | Barclays | Overweight |
| 2019-05-13 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 開始されました | UBS | Buy |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-10-02 | 繰り返されました | Morgan Stanley | Overweight |
| 2018-09-07 | 繰り返されました | Needham | Strong Buy |
| 2018-09-04 | アップグレード | Jefferies | Hold → Buy |
| 2018-07-06 | 繰り返されました | Needham | Strong Buy |
| 2018-06-27 | 開始されました | Bernstein | Outperform |
| 2018-04-26 | 繰り返されました | Needham | Strong Buy |
すべてを表示
Boston Scientific Corp (BSX) 最新ニュース
Boston Scientific’s Quarterly Earnings Preview: What You Need to Know - Barchart.com
Stifel Cuts PT on Boston Scientific Corporation (BSX)- Here’s Why - Yahoo Finance
Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo! Finance Canada
Boston Scientific Corp. stock outperforms competitors despite losses on the day - MarketWatch
symbol__ Stock Quote Price and Forecast - CNN
Boston Scientific Stock (BSX) Opinions on Recent Analyst Downgrades - Quiver Quantitative
Boston Scientific adjusts growth outlook as stock struggles. Guidance cuts weigh on sentiment - AD HOC NEWS
Boston Scientific (BSX) Invests $1.5B in MiRus for Equity Stake and TAVR Acquisition Option - Insider Monkey
Boston Scientific Corp. stock underperforms Monday when compared to competitors - MarketWatch
Boston Scientific stock hits 52-week low at 43.87 USD By Investing.com - Investing.com South Africa
Boston Scientific stock hits 52-week low at 43.87 USD - Investing.com
Boston Scientific strategy focus, shares hold in S&P 500 healthcare group - AD HOC NEWS
The WATCHMAN FLX Pro from Boston Scientific Corp.left atrial appendage closure gets smoother in c - Ad-hoc-news.de
World Implantable Neurostimulation DevicesMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
WAYCROSS PARTNERS, LLC's Boston Scientific Corp(BSX) Holding History - GuruFocus
Is Boston Scientific (BSX) One of the Best Low Volatility Stocks to Buy Under $50? - Insider Monkey
Brain Implants Market Size to Reach USD 18.39 Billion by 2035, Growing at 9.99% CAGR | SNS Insider - GlobeNewswire Inc.
Boston Scientific Corp Investor Event at the Scientific Session of the American College of Cardiology Transcript - GuruFocus
Volkswagen Plans to Cut Up to 100,000 Jobs and Close 4 German Plants, European Auto Industry Faces Historic Restructuring - TradingKey
Boston Scientific Options Spot-On: On June 25th, 67,433 Contracts Were Traded, With 779.57K Open Interest - Moomoo
Boston Scientific (NYSE:BSX) Gains Fresh Market Attention - Kalkine Media
BSX Maintained by Stifel -- Price Target Lowered to $65.00 - GuruFocus
TD Cowen Maintains a Buy Rating on Boston Scientific (BSX) - Insider Monkey
Stifel Adjusts Price Target on Boston Scientific to $65 From $75, Maintains Buy Rating - marketscreener.com
Japan, South Korea Stocks Rally; Nikkei 225 Nears Previous High, Kospi Rises Over 5%, Memory Giants SK Hynix and Kioxia Soar Over 12% - TradingKey
Boston Scientific (BSX) Registers a Bigger Fall Than the Market: Important Facts to Note - sharewise.com
Micron Q3 Data Center Revenue Grows Over Sevenfold YoY; Shares Jump Over 14% Post-Market, Memory Supply Shortage to Last Beyond 2027 - TradingKey
How a Targeted Valve Recall and Watchman Questions at Boston Scientific (BSX) Have Changed Its Investment Story - Yahoo Finance
Boston Scientific (BSX) Recalls Orca Valves Nationwide After Device Malfunction - Yahoo Finance
BSX Maintains Buy Rating by Jefferies -- Price Target Lowered to $67.00 - GuruFocus
BSX Stock | Boston Scientific Corp Q1 2025 Earnings Call Bear Attack (FjRIiYMEgO) - Mshale
Boston Scientific (BSX) Faces 52.54% Decline Amid Weak Momentum Grades - GuruFocus
IBM (IBM) Rebounds 5% on ServiceNow AI Deal — Can It Clear $267 Resistance? - TradingKey
Jefferies Adjusts Price Target on Boston Scientific to $67 From $100, Maintains Buy Rating - marketscreener.com
Analyst recommendations: Astera Labs, Boston Scientific, Cognizant Technologies, Fedex… - marketscreener.com
Boston Scientific Corp (BSX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Boston Scientific (BSX) Gains As Market Dips: What You Should Know - Yahoo Finance
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Piper Sandler Maintains Overweight Rating for Boston Scientific (BSX) - Insider Monkey
Jim Cramer on Boston Scientific: “This Whole Cohort Is Just Too Hard to Own” - Insider Monkey
Here’s How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years - Benzinga
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
Boston Scientific stock hits 52-week low at 44.41 USD By Investing.com - Investing.com Australia
Boston Scientific Spinal Cord Stimulator Lawsuit for SCS Injuries - robertkinglawfirm.com
Boston Scientific stock hits 52-week low at 44.41 USD - Investing.com UK
Truist Cuts Boston Scientific (BSX) ’s Target as Doctors Change How They Use Its Heart Device - Insider Monkey
Cramer Passes On NioCorp And SoundHound — But Says One Stock Is 'Time To Buy' - Benzinga
Boston Scientific Corp Recalls Orca Sterile Single-Use Air/Water and Suction Valves - marketscreener.com
Boston Sci-Mirus pact lifts med-tech dealmaking to record $4.5B in May - BioWorld News
Boston Scientific Corp (BSX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Boston Scientific Corp (BSX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Boston Scientific Corp (BSX) 財務データ
収益
当期純利益
現金流量
EPS
Boston Scientific Corp (BSX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Pegus Cheryl | Director |
May 20 '26 |
Buy |
56.49 |
1,770 |
99,987 |
1,770 |
| LUDWIG EDWARD J | Director |
May 20 '26 |
Buy |
56.68 |
3,580 |
202,914 |
25,359 |
| Habiger David C | Director |
May 20 '26 |
Buy |
55.92 |
2,250 |
125,819 |
13,878 |
| Habiger David C | Director |
May 19 '26 |
Buy |
56.95 |
2,200 |
125,279 |
11,628 |
| O'Connor Padraig Andrew | EVP, Global Operations |
May 02 '26 |
Option Exercise |
0.00 |
1,802 |
0 |
7,896 |
| Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
May 02 '26 |
Option Exercise |
0.00 |
2,102 |
0 |
57,894 |
| Woodworth Emily | SVP, Global Controller and CAO |
Mar 01 '26 |
Option Exercise |
0.00 |
838 |
0 |
3,231 |
| O'Connor Padraig Andrew | EVP, Global Operations |
Feb 16 '26 |
Option Exercise |
0.00 |
905 |
0 |
6,433 |
| O'Connor Padraig Andrew | EVP, Global Operations |
Feb 14 '26 |
Option Exercise |
0.00 |
1,190 |
0 |
5,977 |
| O'Connor Padraig Andrew | EVP, Global Operations |
Feb 13 '26 |
Option Exercise |
0.00 |
500 |
0 |
4,986 |
大文字化:
|
ボリューム (24 時間):